Preview

Psychiatry (Moscow) (Psikhiatriya)

Advanced search

The State of Monoamine Activity in Children with Tyc Hyperkinesis and the Combined Type of Attention Deficit Hyperactivity Disorder (ADHD)

https://doi.org/10.30629/2618-6667-2021-19-2-46-54

Abstract

Aim: the primary purpose of this study was to explore the state of monoamine activity in children with tic disorder at a combined type of attention deficit disorder (ADHD).

Patients and methods: 404 children aged 6–10 years with a combined type of ADHD were divided into three subgroups according to the monoamine activity: 1 subgroup with a combination of hypofunction of dopaminergic and hyperfunction of the noradrenergic system — 120 patients, 2 subgroup with a combination of hyperfunction of the noradrenergic system with a relative balance of dopamine — 136 patients, 3 subgroups with biochemical parameters of monoamine indicators within the reference values — 148 children. The levels of monoamines, their precursors and metabolic products in daily urine were determined by high performance liquid chromatography with electrochemical detection: dopamine, norepinephrine, adrenaline and serotonin, their metabolites — homovanilic acid, vanillylmandelic acid, 5-hydroxytryptophan and 5-hydroxyindoleacetic acid, and their precursors tryptophan and tyrosine. To assess the severity of the symptoms of ADHD, the SNAP-IV scale was used, and tic severity was determined using the Yale global tick severity scale.

Results: сommon to all subgroups under consideration is characteristic that the severity of the tick correlates, fi rst, with increased impulsivity (1 subgroup р = 0.0001, 2 subgroup р = 0.045, 3 subgroup р = 0.015). The degree of manifestation of the main symptoms of ADHD in children has competitive behavior with tics, which is associated with decompensation of the biochemical balance of monoamine systems. In subgroup 1, there is an increase in the consumption of norepinephrine (p = 0.002) with a large formation of metabolites and a further weakening of the activity of the dopamine (p = 0.029) and serotonin (p = 0.038) systems. In subgroup 2, the dopamine system is deficient (p = 0.001) and the inhibitory function of the serotonin system increases (p = 0.003). In subgroup 3, the activity of the noradrenaline system increases with minimal participation of the dopamine system and a weakening of the influence of the serotonin system (p = 0.006).

Conclusion: in cases of comorbidity of ADHD and tic disorder in children, observation revealed a change in the state of noradrenergic and dopamine systems and weakening of the inhibitory effect of serotonin, which probably has an effect on the general psychopathological profile.

About the Authors

R. F. Gasanov
V.M. Bekhterev National Research Medical Center for Psychiatry and Neurology
Russian Federation

Rauf F. Gasanov, MD, PhD, Cand. of Sci. (Med.), Leading Researcher, Department of Child Psychiatry

Saint Petersburg



I. V. Makarov
V.M. Bekhterev National Research Medical Center for Psychiatry and Neurology; North-Western State Medical University named after I.I. Mechnikov
Russian Federation

Igor V. Makarov, MD, PhD, Dr. of Sci. (Med.), Head of the Department of Child Psychiatry; Professor of the Department of Psychiatry and Narcology

Saint Petersburg



D. A. Emelina
V.M. Bekhterev National Research Medical Center for Psychiatry and Neurology
Russian Federation

Daria A. Emelina, MD, PhD, Cand. of Sci. (Med.), Researcher, Department of Child Psychiatry

Saint Petersburg



References

1. Luo Y, Weibman D, Halperin JM, Li X. A Review of Heterogeneity in Attention Deficit/Hyperactivity Disorder (ADHD). Front Hum. Neurosci. 2019;13:42. doi: 10.3389/fnhum.2019.00042

2. Saad JF, Griffi ths KR, Korgaonkar MS. A Systematic Review of Imaging Studies in the Combined and Inattentive Subtypes of Attention Defi cit Hyperactivity Disorder. Front Integr. Neurosci. 2020;14:31. doi: 10.3389/fnint.2020.00031

3. Fournier A, Gauthier B, Guay M-C, Parent V. Design Fluency in Children with ADHD and Comorbid Disorders. Brain Sci. 2020;10(3):172. doi: 10.3390/brainsci10030172

4. Oluwabusi OO, Paul S, Ambrosini PJ. Tourette syndrome associated with attention deficit hyperactivity disorder: The impact of tics and psychopharmacological treatment options. World J. Clin. Pediatr. 2016;5(1):128–135. doi: 10.5409/wjcp.v5.i1.128

5. Albin RL. Tourette syndrome: a disorder of the social decision-making network. Brain. 2017;141(2):332– 347. doi:10.1093/brain/awx204

6. Hienert M, Gryglewski G, Stamenkovic M, Kasper S, Lanzenberge R. Striatal dopaminergic alterations in Tourette’s syndrome: a meta-analysis based on 16 PET and SPECT neuroimaging studies. Transl Psychiatry. 2018;8:143. doi: 10.1038/s41398-018-0202-y

7. Yoon DY, Gause CD, Leckman JF, Singer H. Frontal dopaminergic abnormality in Tourette syndrome: a postmortem analysis. J. Neurol. Sci. 2007;255(1– 2):50–56. doi: 10.1016/j.jns.2007.01.069

8. Singer HS, Minzer K. Neurobiology of Tourette syndrome: concepts of neuroanatomical localization and neurochemical abnormalities. Brain Dev. 2003;25(Suppl.1):S70–84. doi: 10.1016/s0387- 7604 (03)90012-x

9. Wang Y, Li A. Regulatory effects of Ningdong granule on dopaminergic and serotonergic neurotransmission in a rat model of Tourette syndrome assessed by PET. Molecular Medicine Reports. 2019;20(1):191–197. doi: 10.3892/mmr.2019.10243

10. Wong DF, Brasic JR, Singer HS, Schretlen DJ, Kuwabara H, Zhou Y, Nandi A, Maris MA, Alexander M, Ye W, Rousset O, Kumar A, Szabo Z, Gjedde A, Grace AA. Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: clues from an in vivo neurochemistry study with PET. Neuropsychopharmacology. 2008;33(6):1239–1251. doi: 10.1038/ sj.npp.1301528

11. Pringsheim T, Holler-Managan Y, Okun MS., Jankovic J, Piacentini J, Cavanna AE., Martino D, Müller-Vahl K, Woods DW, Robinson M, Jarvie E, Roessner V, Oskoui M. Comprehensive systematic review summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology. 2019;92(19):907– 915. doi: 10.1212/WNL.0000000000007467

12. Gasanov RF, Makarov IV. Monoamine metabolism in children with hyperkinetic disorder. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova. 2017;117(11–2):88– 91. (In Russ.). doi: 10.17116/jnevro201711711288-91

13. Swanson JM. School-based assessments and interventions for ADD students. Irvine: K.C. Publishing, 1992.

14. Leckman JF, Riddle MA, Hardin MT, Ort SI, Swartz KL, Stevenson J. The Yale Global Tic Severity Scale: initial testing of a clinicianrated scale of tic severity. J. Am. Acad. Child Adolesc. Psychiatry. 1989;28(4):566– 573. doi: 10.1097/00004583-198907000-00015

15. Textbook of Clinical Chemistry and Molecular Diagnostics. 4nd ed. Elsevier: New Delhi; 2006.

16. Ma I, Holstein MV, Mies G, Mennes M, Scheres A. Ventral striatal hyperconnectivity during rewarded interference control in adolescents with ADHD. Cortex. 2016;82:225–236. doi: 10.1016/j.cortex.2016.05.021

17. Morello F, Voikar V, Parkkinen P, Panhelainen A, Rosenholm M, Makkonen A, Rantamäki T, Piepponen P, Aitta-Aho T, Partanen J. ADHD-like behaviors caused by inactivation of a transcription factor controlling the balance of inhibitory and excitatory neuron development in the mouse anterior brainstem. Transl. Psychiatry. 2020;10(1):357. doi: 10.1038/s41398-020- 01033-8

18. Стал СМ. Основы психофармакологии. Теория и практика. М.: ГЭОТАР-Медиа, 2019.

19. Stahl SM. Essential Psychopharmacology. Theory and Practical Applications. M.: GEOTAR-Media, 2019. (In Russ.).

20. Fedoseeva IF, Poponnikova TV, Veremeev AV. Noradrenaline state in children with a tic disorders. Byulleten’ sibirskoj mediciny. 2009;1(2):87–90. (In Russ.).


Review

For citations:


Gasanov R.F., Makarov I.V., Emelina D.A. The State of Monoamine Activity in Children with Tyc Hyperkinesis and the Combined Type of Attention Deficit Hyperactivity Disorder (ADHD). Psychiatry (Moscow) (Psikhiatriya). 2021;19(2):46-54. (In Russ.) https://doi.org/10.30629/2618-6667-2021-19-2-46-54

Views: 881


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1683-8319 (Print)
ISSN 2618-6667 (Online)